{"id":"https://openalex.org/W7225322156","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","title":"606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM","display_name":"606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225322156","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0606"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0606","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A685.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A685.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021064713","display_name":"Tyler M. Johnston","orcid":"https://orcid.org/0009-0001-3677-1574","observed_orcids":["https://orcid.org/0009-0001-3677-1574"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tyler M Johnston","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113910429","display_name":"Yoshinari Osada","orcid":"https://orcid.org/0009-0000-1041-0044","observed_orcids":["https://orcid.org/0009-0000-1041-0044"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshinari Osada","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109821385","display_name":"Gabrielle Kizeev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabrielle Kizeev","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015024117","display_name":"Pravesh Gupta","orcid":"https://orcid.org/0000-0002-1643-8950","observed_orcids":["https://orcid.org/0000-0002-1643-8950"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pravesh Gupta","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210127938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047813770","display_name":"Matthias Brendel","orcid":"https://orcid.org/0000-0002-9247-2843","observed_orcids":["https://orcid.org/0000-0002-9247-2843","https://orcid.org/0000-0002-6522-4895"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Brendel","raw_affiliation_strings":["Ludwig-Maximilians University Munich, Munich, Bavaria, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig-Maximilians University Munich, Munich, Bavaria, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006121966","display_name":"Kai Schlepckow","orcid":"https://orcid.org/0000-0002-1119-2293","observed_orcids":["https://orcid.org/0000-0002-1119-2293"]},"institutions":[{"id":"https://openalex.org/I2801533059","display_name":"German Center for Neurodegenerative Diseases","ror":"https://ror.org/043j0f473","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I2801533059","https://openalex.org/I4405256427"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kai Schlepckow","raw_affiliation_strings":["German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany","institution_ids":["https://openalex.org/I2801533059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065084452","display_name":"Christian Haass","orcid":"https://orcid.org/0000-0002-4869-1627","observed_orcids":["https://orcid.org/0000-0002-4869-1627"]},"institutions":[{"id":"https://openalex.org/I2801533059","display_name":"German Center for Neurodegenerative Diseases","ror":"https://ror.org/043j0f473","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I2801533059","https://openalex.org/I4405256427"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Haass","raw_affiliation_strings":["German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany","Ludwig-Maximilians University Munich, Munich, Bavaria, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany","institution_ids":["https://openalex.org/I2801533059"]},{"raw_affiliation_string":"Ludwig-Maximilians University Munich, Munich, Bavaria, Germany","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005881707","display_name":"Kathryn M. Monroe","orcid":"https://orcid.org/0000-0002-6901-1176","observed_orcids":["https://orcid.org/0000-0002-6901-1176"]},"institutions":[{"id":"https://openalex.org/I4210097160","display_name":"Denali Therapeutics (United States)","ror":"https://ror.org/00pprn321","country_code":"US","type":"company","lineage":["https://openalex.org/I4210097160"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn Monroe","raw_affiliation_strings":["Denali Therapeutics, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Denali Therapeutics, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210097160"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070213081","display_name":"Krishna Bhat","orcid":"https://orcid.org/0000-0002-2020-8509","observed_orcids":["https://orcid.org/0000-0002-2020-8509"]},"institutions":[{"id":"https://openalex.org/I4210127938","display_name":"Mayo Clinic Hospital","ror":"https://ror.org/03660jn93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4210127938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Krishna Bhat","raw_affiliation_strings":["Mayo Clinic, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I4210127938"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A685","last_page":"A685"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5375999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5375999808311462,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.4332999885082245,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.010499999858438969,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8790000081062317},{"id":"https://openalex.org/keywords/transferrin-receptor","display_name":"transferrin receptor","score":0.9739999771118164},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.8809999823570251},{"id":"https://openalex.org/keywords/anti-pd-1-combination-therapy","display_name":"anti-PD-1 combination therapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8600000143051147},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8859999775886536},{"id":"https://openalex.org/keywords/microglial-polarization","display_name":"microglial polarization","score":0.7850000262260437},{"id":"https://openalex.org/keywords/myeloid-activation","display_name":"myeloid activation","score":0.7210000157356262},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.765999972820282},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.5460000038146973},{"id":"https://openalex.org/keywords/soluble-trem2","display_name":"soluble TREM2","score":0.7080000042915344},{"id":"https://openalex.org/keywords/immunological-memory","display_name":"immunological memory","score":0.7350000143051147},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.5820000171661377},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5809999704360962},{"id":"https://openalex.org/keywords/orthotopic-glioma-model","display_name":"orthotopic glioma model","score":0.593999981880188},{"id":"https://openalex.org/keywords/trem2-knockout-mice","display_name":"TREM2 knockout mice","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2779685842","wikidata":"https://www.wikidata.org/wiki/Q18040973","display_name":"TREM2","level":4,"score":0.6887999773025513},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6525999903678894},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6295999884605408},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5824000239372253},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5367000102996826},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5066999793052673},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.486299991607666},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.4553999900817871},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45190000534057617},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4433000087738037},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.44179999828338623},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4311999976634979},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4097999930381775},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3709999918937683},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.3522000014781952},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3483000099658966},{"id":"https://openalex.org/C2779958370","wikidata":"https://www.wikidata.org/wiki/Q5711176","display_name":"Hematopoietic growth factor","level":4,"score":0.3375000059604645},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.3343999981880188},{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.31119999289512634},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.3098999857902527},{"id":"https://openalex.org/C160448771","wikidata":"https://www.wikidata.org/wiki/Q184726","display_name":"Phagocytosis","level":2,"score":0.30889999866485596},{"id":"https://openalex.org/C10882517","wikidata":"https://www.wikidata.org/wiki/Q15268054","display_name":"Cell therapy","level":3,"score":0.3034999966621399},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.302700012922287},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.2809000015258789},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.2734000086784363},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.258899986743927},{"id":"https://openalex.org/C196822366","wikidata":"https://www.wikidata.org/wiki/Q270524","display_name":"Parenchyma","level":2,"score":0.2531000077724457},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.25110000371932983}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0606","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A685.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0606","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0606","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A685.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225322156.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4376507134","https://openalex.org/W4388589625","https://openalex.org/W4309013979","https://openalex.org/W4398234646","https://openalex.org/W4399400465","https://openalex.org/W4308977981","https://openalex.org/W7128591871","https://openalex.org/W4390964365","https://openalex.org/W4388539639","https://openalex.org/W7167054064"],"abstract_inverted_index":{"Background":[0],"While":[1,169],"immunotherapy":[2,375],"such":[3],"as":[4,49,249,251,320,370,407],"immune":[5,345],"checkpoint":[6],"blockade":[7,194],"(ICB)":[8],"has":[9,17],"proven":[10],"successful":[11],"in":[12,21,56,109,158,226,278,334,377,386],"treating":[13,399],"peripheral":[14],"cancers,":[15],"it":[16],"shown":[18],"limited":[19],"efficacy":[20],"glioblastoma":[22],"(GBM).":[23],"Here,":[24],"we":[25],"tested":[26],"a":[27,260,321,371,395,408],"TREM2":[28,120,138,148,153,363,391],"agonist":[29],"antibody":[30,45],"that":[31,316,342,390],"was":[32,116,218,285],"engineered":[33],"to":[34,52,62,103,146,188,224,347,410,416],"cross":[35],"the":[36,57,69,110,126,151,159,230,236,343,353,417],"blood-brain":[37],"barrier":[38],"by":[39,243,275,288,352],"binding":[40,139],"transferrin":[41],"receptor":[42],"(TfR),":[43],"termed":[44],"transport":[46],"vehicle":[47],"(ATV),":[48],"an":[50],"approach":[51],"activate":[53],"myeloid":[54,244,257,272,301],"cells":[55,155,245,280,302],"GBM":[58,133,348],"tumor":[59,160,182,242],"microenvironment":[60],"(TME)":[61],"support":[63],"T":[64],"cell":[65],"function":[66],"and":[67,97,106,112,123,131,141,180,202,262,336,355],"bolster":[68],"ICB":[70,366],"response.Methods":[71],"Human":[72],"TfR":[73],"knock-in":[74],"mice":[75,143,210],"were":[76,101,144,156],"implanted":[77],"with":[78,93,163,192,206,220,365,403],"orthotopic":[79],"CT2A-ZsGreen-Luc":[80],"glioma":[81],"before":[82],"administration":[83],"of":[84,129,136,208,232,241,271,330,358,362,381,413],"ATV:TREM2":[85],"(ATV:4D9)":[86],"or":[87,92],"isotype":[88],"(ATV:ISO)":[89],"antibody,":[90],"alone":[91,172],"anti-PD-1.":[94],"Flow":[95],"cytometry":[96,290],"EdU":[98,276],"uptake":[99,277],"experiments":[100],"used":[102,145],"profile":[104],"functional":[105],"phenotypic":[107],"changes":[108],"TME,":[111,237],"cerebrospinal":[113],"fluid":[114],"(CSF)":[115],"assayed":[117],"for":[118,134,323,373,398],"soluble":[119],"(sTREM2).":[121],"MALDI":[122],"LC-MS":[124],"assessed":[125],"lipid":[127],"composition":[128],"human":[130,335],"murine":[132,337],"identification":[135,380],"potential":[137,382],"partners,":[140],"Trem2-mKate2":[142],"probe":[147],"expression":[149],"within":[150],"TME.Results":[152],"+":[154],"enriched":[157,385],"core":[161],"compared":[162],"adjacent":[164],"parenchyma":[165],"(p":[166,177,184,199,246,281,295,312],"=":[167,178,185,200,204,247,296,313],"0.0167).":[168],"ATV:4D9":[170,238,267],"treatment":[171,268,311,324],"prolonged":[173],"median":[174],"overall":[175],"survival":[176],"0.0314)":[179],"decreased":[181,308],"burden":[183],"0.04)":[186],"relative":[187],"ATV:ISO,":[189],"combination":[190],"therapy":[191],"PD-1":[193],"significantly":[195],"improved":[196],"these":[197,359,414],"metrics":[198],"0.0005":[201],"p":[203],"0.0008),":[205],"7":[207],"9":[209],"completely":[211],"rejecting":[212],"their":[213],"tumors.":[214],"Protection":[215],"from":[216],"rechallenge":[217],"demonstrated":[219],"re-implanted":[221],"tumors":[222,388],"failing":[223],"grow":[225],"cured":[227],"mice,":[228],"suggesting":[229,341],"formation":[231],"immunologic":[233],"memory.":[234],"Within":[235],"induced":[239,269],"phagocytosis":[240],"0.0231),":[248],"well":[250],"polarizing":[252],"microglia,":[253],"but":[254,298],"not":[255,299],"other":[256,300],"populations,":[258],"toward":[259],"pro-inflammatory":[261],"antigen-presenting":[263],"phenotype.":[264],"Further,":[265],"acute":[266],"proliferation":[270],"populations":[273],"measured":[274],"IBA1+":[279],"<":[282],"0.05),":[283],"which":[284],"orthogonally":[286],"confirmed":[287],"flow":[289],"showing":[291],"increased":[292],"Ki-67+":[293],"microglia":[294],"0.0002)":[297],"after":[303,310],"treatment.":[304],"CSF":[305,404],"profiling":[306],"showed":[307],"sTREM2":[309,405],"0.0226),":[314],"indicating":[315],"this":[317],"could":[318],"serve":[319],"biomarker":[322,409],"efficacy.":[325],"Lipidomic":[326],"studies":[327],"identified":[328],"enrichment":[329],"candidate":[331],"TREM2-binding":[332,383],"lipids":[333,384],"mesenchymal":[338,387],"subtype":[339],"GBM,":[340],"TREM2-dependent":[344],"response":[346],"may":[349,393],"be":[350],"modulated":[351],"genotype":[354],"metabolic":[356],"properties":[357],"tumors.Conclusions":[360],"Synergy":[361],"agonism":[364,392],"suggests":[367],"its":[368],"utility":[369],"method":[372],"boosting":[374],"responsiveness":[376],"GBM.":[378],"The":[379],"implies":[389],"fill":[394],"clinical":[396],"niche":[397],"aggressive":[400],"disease":[401],"subtypes,":[402],"serving":[406],"enable":[411],"translation":[412],"data":[415],"clinic.":[418]},"counts_by_year":[],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2026-11-06T00:00:00"}
